UMass Chan scientists show ribosomes play unexpected role in blood vessel formation
Research by Andrei Korostelev, PhD, and Anna Loveland, PhD, shows that the ribosome plays an unexpected role in the activation of angiogenin, allowing it to cleave transfer RNA, thereby halting protein production. These findings shed new light on angiogenin functioning and may have important implications for the design of cancer therapeutics and neurodegenerative disease treatments.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, RNA Therapeutics Institute, Microbiology and Physiological Systems, Latest News, Andrei Korostelev, Top Stories,
Aug 3, 2023
UMass Chan BRIDGE Fund invests nearly $2M in 13 faculty projects
The BRIDGE Fund supports critical research milestones for inventions and discoveries that have high potential to change the course of disease and continues to grow, increasing from approximately $1 million per year in 2019 to $3 million in 2024.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Dermatology, Medicine, Cancer Center, Faculty, Award, Research, Craig Ceol, Dohoon Kim, Paul R. Thompson, Sontheimer Lab, Harris Lab, John Harris, Molecular, Cell and Cancer Biology, RNA Therapeutics Institute, Microbiology and Physiological Systems, Program in Molecular Medicine, Celia Schiffer, Schiffer Lab, Latest News, Andrei Korostelev, Biochemistry and Molecular Biotechnology, Erik Sontheimer, BRIDGE, Top Stories, Fiachra Humphries,
May 3, 2022
Communicating science: Andrei Korostelev using structural biology to tackle antibiotic resistance
A recent survey of health care professionals showed nearly 60 percent of participants encountered patients whose infections didn’t respond to any antibiotic. Andrei Korostelev, PhD, says by studying the biology of bacterial cells, effective new antibiotics can be developed.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, RNA Therapeutics Institute, Andrei Korostelev,
